Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-037447

President and CEO gave up 44,818 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2026-03-30 Shares withheld for taxes −44,818 $3.31 $148,348 3,422,243 D
Loading xslF345X06/ownership.xml…